InterCure (INCR) Competitors

InterCure (NASDAQ:INCR) and Rezolute (NASDAQ:RZLT) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, community ranking, risk, institutional ownership, valuation, media sentiment, dividends, analyst recommendations and earnings.

Do analysts rate INCR or RZLT?

Rezolute has a consensus price target of $24.13, suggesting a potential upside of 449.54%. Given Rezolute's stronger consensus rating and higher probable upside, analysts plainly believe Rezolute is more favorable than InterCure.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
InterCure	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Rezolute	0 Sell rating(s)	0 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	3.00

Which has better earnings and valuation, INCR or RZLT?

InterCure has higher revenue and earnings than Rezolute.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
InterCure	$272.67M	0.25	-$16.83M	N/A	N/A
Rezolute	N/A	N/A	-$68.46M	-$1.27	-3.46

Does the MarketBeat Community favor INCR or RZLT?

Rezolute received 64 more outperform votes than InterCure when rated by MarketBeat users. However, 100.00% of users gave InterCure an outperform vote while only 78.82% of users gave Rezolute an outperform vote.

Company	Underperform	Outperform
InterCure	Outperform Votes 3 100.00%	Underperform Votes No Votes
Rezolute	Outperform Votes 67 78.82%	Underperform Votes 18 21.18%

Does the media favor INCR or RZLT?

In the previous week, Rezolute had 2 more articles in the media than InterCure. MarketBeat recorded 4 mentions for Rezolute and 2 mentions for InterCure. Rezolute's average media sentiment score of 1.60 beat InterCure's score of 0.00 indicating that Rezolute is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
InterCure	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Rezolute	3 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Do insiders & institutionals believe in INCR or RZLT?

8.3% of InterCure shares are held by institutional investors. Comparatively, 83.0% of Rezolute shares are held by institutional investors. 0.2% of InterCure shares are held by company insiders. Comparatively, 18.4% of Rezolute shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Is INCR or RZLT more profitable?

InterCure's return on equity of 0.00% beat Rezolute's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
InterCure	N/A	N/A	N/A
Rezolute	N/A	-69.83%	-62.16%

Which has more volatility and risk, INCR or RZLT?

InterCure has a beta of 1.37, suggesting that its stock price is 37% more volatile than the S&P 500. Comparatively, Rezolute has a beta of 1.01, suggesting that its stock price is 1% more volatile than the S&P 500.

Summary

Rezolute beats InterCure on 8 of the 14 factors compared between the two stocks.